| ACRS |
Aclaris Therapeutics, Inc. |
01 Jan 2024 |
3 |
-$9,581 |
4 |
Pres and CEO, Director |
03 Jan 2024, 16:44 |
| ACRS |
Aclaris Therapeutics, Inc. |
01 Aug 2023 |
3 |
-$43,527 |
4 |
Pres and CEO, Director |
03 Aug 2023, 16:24 |
| ACRS |
Aclaris Therapeutics, Inc. |
17 Mar 2023 |
1 |
+$49,532 |
4 |
Pres and CEO, Director |
17 Mar 2023, 17:03 |
| ACRS |
Aclaris Therapeutics, Inc. |
09 Mar 2023 |
1 |
+$50,278 |
4 |
Pres and CEO, Director |
09 Mar 2023, 16:56 |
| ACRS |
Aclaris Therapeutics, Inc. |
01 Feb 2023 |
2 |
$0 |
4 |
Pres and CEO, Director |
03 Feb 2023, 16:04 |
| ACRS |
Aclaris Therapeutics, Inc. |
01 Aug 2022 |
2 |
$0 |
4 |
Pres and COO |
02 Aug 2022, 17:10 |
| ACRS |
Aclaris Therapeutics, Inc. |
01 Aug 2022 |
0 |
$0 |
3 |
Pres and COO |
02 Aug 2022, 17:06 |
| /report/000162828022005892-manion-douglas-j-2022-03-11 |
ARENA PHARMACEUTICALS INC |
11 Mar 2022 |
4 |
$0 |
4 |
EVP Research & Development |
11 Mar 2022, 15:12 |
| /report/000162828022000342-manion-douglas-j-2022-01-03 |
ARENA PHARMACEUTICALS INC |
03 Jan 2022 |
1 |
$0 |
4 |
EVP Research & Development |
05 Jan 2022, 16:02 |
| /report/000162828021017169-manion-douglas-j-2021-08-15 |
ARENA PHARMACEUTICALS INC |
15 Aug 2021 |
3 |
$0 |
4 |
EVP Research & Development |
17 Aug 2021, 08:30 |
| /report/000162828021014938-manion-douglas-j-2021-07-19 |
ARENA PHARMACEUTICALS INC |
19 Jul 2021 |
0 |
$0 |
3 |
EVP Research & Development |
29 Jul 2021, 18:19 |